Navigation Links
Statement by Daniel W. Jones, M.D., American Heart Association President on President Bush's FY 2009 Budget Proposal
Date:2/5/2008

WASHINGTON, Feb. 5 /PRNewswire-USNewswire/ -- Following is a statement by Daniel W. Jones, M.D., American Heart Association President:

With his last budget, the president had an opportunity to leave his mark in the fight against cardiovascular disease, our nation's No. 1 killer and costliest disease. Instead, his proposal will cut resources that would bring us closer to a cure. We're making steady progress in combating heart disease and stroke, but that momentum will be lost if research and prevention programs fall victim to heartless budget cuts.

We are deeply troubled that funding for heart and stroke research at the National Institutes of Health (NIH) is below medical research inflation for the sixth year in a row. With our economy in decline, we had hoped that the president would have recognized the strong link between medical research and economic growth. By making a substantial investment in NIH, our elected leaders could promote a strong and vigorous research enterprise that will save lives and boost the economy.

Heart disease and stroke prevention programs funded through the Centers for Disease Control and Prevention (CDC) also help Americans live longer, more productive lives. Unfortunately, proposed funding for these programs was cut as well. Even though cardiovascular disease is the No. 1 killer in all 50 states, only 13 currently receive funding to implement prevention programs for heart disease and stroke. The president also zeroed out a successful program to improve sudden cardiac arrest survival rates in rural communities by providing them with automated external defibrillators.

More than 80 million Americans suffer from cardiovascular disease and pay exorbitant medical costs. Quality and affordable care should be paramount yet the president has proposed cuts in Medicare and Medicaid, reducing access for millions of Americans -- with often tragic consequences.

As Congress debates the president's prop
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NCPA Statement in Response to President Bushs FY 2009 Budget Proposal
2. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
3. Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY09
4. NutraCea Files Universal Shelf Registration Statement
5. AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform
6. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
7. Statement of Robert K. Ross, M.D.
8. NCPA Statement on Wal-Marts Entry Into the Pharmacy Benefit Market
9. Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
10. Statement by Bruce Bodaken on Senate Health Committee Action
11. AASM statement on use of sleep medications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire/--TheGuardianLifeInsuranceCompanyofAmerica(Gu...ngproviderofemployeebenefitsforsmallandmid-sizedco...followitscurrentinsurancecoverageguidelinesformamm...theAmericanCancerSocietyandAmericanMedicalAssociat..., Recently,TheU.S.PreventiveServicesTaskForcere...
(Date:11/24/2009)...SPSTFRepresentationandRecommendationProcess ,,...lsectionsofSenatehealthcarereformlegislation conta...ivateinsurers,MedicareandMedicaidwouldonlyberequir....PreventativeServicesTaskForce.Presently,thiswould...equirecoverageofbiennial(everyotheryear)coveragefo...
(Date:11/24/2009)... 24, 2009 Researchers at Ben-Gurion University of...s cancerous skin tumors, including melanomas that ...l testing, the OSPI instrument (Optical Spectro-Po...ns that have never been seen before - including me... skin lesions and were awaiting surgery for their ...
(Date:11/24/2009)...ily members of pediatric cancer and hematology pat...nd the medical team, according to a new Indiana Un...ital for Children, where the study was conducted, ...ionwide routinely offering the parents of pediatri...o join their child,s medical team as active partic...
(Date:11/24/2009)...s Conjoint Mid-Winter Meetings Jan. 27Feb. 2, 2010...que, N.M. This year, SNM joins its annual Mid-Wint...ing and Educational Symposium of the American Coll...nd Molecular Imaging Summit and the Clinical Trial...offers participants an outstanding range of scient...
Breaking Medicine News(10 mins):Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:SNM's Conjoint Mid-Winter Meetings offer 4 scientific meetings in 1 location 2
... BridgePoint Medical, LLC,s,partner, Charlotte Or...ay,that Amy Street, CP has joined COPC,s practitio... the responsibility for prosthetic care at the,Cha... with OrPro in,Maryland. She received a Bachelor o...
...Healthcare Services,Inc. (NYSE: AHS ), the nation...ed to make a presentation on Thursday, September 1...6th Annual Best Ideas Conference taking,place at t...ew of the company and will discuss the,company,s c...
... The latest edition,s market trends section cont...g felt throughout larger populated areas. , ..., 2008 --- www.TDCpeople.com [The Delta Companie...summary of current data and market trends in physi...
... Anticipated to promote greater awareness and un..., Zeus presents free webinar on August 28, 2008. ...ugust 22, 2008 -- Zeus, Inc., a leader in polymer ...omaterials." , , ,Presented by Dr. Bruce Anne...
...li Lilly and Co (NYSE:,LLY) and Boehringer Ingelhe... approved the use of Cymbalta(R) (duloxetine) for ...). This approval -- the fourth for,duloxetine in E... for Human Use (CHMP) on 26 June 2008., The appro...
...g Technology Integrated with the Award Winning ...AUBURN, Ala., Aug. 21 CytoViva Inc., a leading pr...chnology research market, has,integrated new hyper...cant advances in a wide range of nano-medicine,and...
Other Medicine News:Health News:Amy Street, Certified Prosthetist and Orthotist, Joins BridgePoint Medical Partner, Charlotte Orthotic and Prosthetic Center (COPC) 2Health News:AMN Healthcare Services to Present at the CL King 6th Annual Best Ideas Conference 2Health News:Physician Recruiting Standard Reveals Larger Populations Experiencing Increased Doctor Shortage 2Health News:Zeus Webinar: Bioabsorbable Polymers as Biomaterials 2Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 2Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 3Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 4Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 5Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 6Health News:CytoViva(R) Introduces Breakthrough Nano-Technology Research Tool 2
(Date:11/24/2009)...RLSBAD,Calif.,Nov.24/PRNewswire-FirstCall/--IsisPh...ensetherapeutics,todayannouncedthatmanagementwillp...althCareConferenceonTuesday,December1,2009,at10:30...castofthepresentationwillbeavailableonthe"Investor...pharm.com .Areplayofthepresentationwillbeavailable...
(Date:11/24/2009)...NMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neurog...ocusedondevelopingandcommercializingnovelpainmanag....OrwintoitsBoardofDirectors,effectiveNovember19,20...biopharmaceuticalindustryandhasbeeninstrumentalint...rwincurrentlyservesasSeniorVicePresident,BioOncolo...
(Date:11/23/2009)...NNYVALE,Calif.,Nov.23/PRNewswire-FirstCall/--Accur...eldofradiosurgery,announcedtodaythatitsmanagementi...thcareConferenceinNewYorkonTuesday,December1,2009a...theJ.P.MorganSmall/MidCapConferenceinNewYorkonThur... Alivewebcastofeachpresentationwillbeavailableonli...
Breaking Medicine Technology:NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2Breathing is No Sweat with New VELCRO 28R 29 Brand EVAPTEX 28TM 29 High Performance Fabric 58155 1Breathing is No Sweat with New VELCRO 28R 29 Brand EVAPTEX 28TM 29 High Performance Fabric 58155 2Breathing is No Sweat with New VELCRO 28R 29 Brand EVAPTEX 28TM 29 High Performance Fabric 58155 3Lilly Endowment Awards 247 Million Grant to Establish Orthopedics and Community Initiative in Kosciusko County IN 14239 1Lilly Endowment Awards 247 Million Grant to Establish Orthopedics and Community Initiative in Kosciusko County IN 14239 2Lilly Endowment Awards 247 Million Grant to Establish Orthopedics and Community Initiative in Kosciusko County IN 14239 3Lilly Endowment Awards 247 Million Grant to Establish Orthopedics and Community Initiative in Kosciusko County IN 14239 4Lilly Endowment Awards 247 Million Grant to Establish Orthopedics and Community Initiative in Kosciusko County IN 14239 5AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture 14234 1AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture 14234 2
...DOYLESTOWN, Pa., Sept. 16 The Quigley,Corporation...ounced positive results,from a follow up study con...rma, http://www.QuigleyPharma.com, designed to e...mpound QR448(a) to prevent the transmission of,Inf...n-infected 2 week old,commercial broiler chickens,...
...ORMD 0901 is Being Developed as an Oral Dosage For...c Control in Adults With Type 2 Diabetes, JERUSAL...Inc. (OTCBB: ORMP.OB), a developer of oral drug de...ed pre-clinical trials of ORMD,0901, a GLP1-analog...ugs which helps to manage,diabetes, including redu...
Other Medicine Technology:Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens 2Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens 4Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 2
Green Straight Fixation Forceps
Castroviejo Fixation Forceps
Straight Dressing Forceps With Serrations - Non-Magnetic
Bishop-Harmon Dressing Forceps
Medicine Products: